August 25, 2020
Weil is advising American Securities in its $825 million acquisition of the life sciences division of NN, Inc., a diversified industrial company. The transaction is expected to close in the fourth quarter of 2020 and is subject to customary closing conditions.
The Weil team advising American Securities is led by Private Equity Co-Head Douglas Warner and includes Private Equity associates Jenna McBain, Theodora Tavridou and Hannah Schmitz (Not Yet Admitted in New York). The team also includes Tax partner Mark Schwed; Executive Compensation & Benefits Head Paul Wessel; Banking & Finance partner Andrew Colao; Technology & IP Transactions partner Jeffrey Osterman; Real Estate partner David Herman; Environmental Head Annemargaret Connolly; Employment Litigation Head Gary Friedman; Executive Compensation & Benefits counsel Craig Olshan; Banking & Finance counsel Young Lee; Regulatory Transactions counsel John O’Loughlin and Timothy Welch; Antitrust/Competition counsel Vadim Brusser; Tax associate Maria Browning (Admitted in Georgia Only); Executive Compensation & Benefits associate Radhika Tahiliani; Banking & Finance associate Jeremy Jenkins; Technology & IP Transactions associate Maryann Thompson; Real Estate associate Joshua Rudin; International Arbitration & Trade associate Nathan Cunningham; Antitrust/Competition associates Dan Nobil and Elizabeth Ross; and Employment Litigation associate Thomas McCarthy.